SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares

    NEXT STORY
    iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage
    PREV STORY
    Translate Bio Announces Proposed Public Offering of Common Stock
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Radius Health to Present Data on Abaloparatide at ASBMR 2018 Annual Meeting

    WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a ...

    author_avatar
    NASDAQ Market News

    Teneobio Announces Research Collaboration with Janssen to Develop Multispecific Antibodies for Oncology 

    MENLO PARK, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation ...

    author_avatar
    NASDAQ Market News

    Stemline Therapeutics Announces Clinical Presentations of SL-801 and SL-701 at the Upcoming ASCO Annual Meeting

    author_avatar
    NASDAQ Market News